New York State Common Retirement Fund’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.6K | Hold |
12,732
| – | – | ﹤0.01% | 3031 |
|
|
2026
Q1 | $49.1K | Hold |
12,732
| – | – | ﹤0.01% | 2822 |
|
|
2025
Q4 | $50K | Hold |
12,732
| – | – | ﹤0.01% | 2907 |
|
|
2025
Q3 | $59.5K | Hold |
12,732
| – | – | ﹤0.01% | 2890 |
|
|
2025
Q2 | $39.6K | Hold |
12,732
| – | – | ﹤0.01% | 3003 |
|
|
2025
Q1 | $43K | Hold |
12,732
| – | – | ﹤0.01% | 2828 |
|
|
2024
Q4 | $72.2K | Hold |
12,732
| – | – | ﹤0.01% | 2729 |
|
|
2024
Q3 | $74.5K | Hold |
12,732
| – | – | ﹤0.01% | 2731 |
|
|
2024
Q2 | $101K | Buy |
12,732
+97
| +0.8% | +$813 | ﹤0.01% | 2829 |
|
|
2024
Q1 | $118K | Sell |
12,635
-28
| -0.2% | -$236 | ﹤0.01% | 2672 |
|
|
2023
Q4 | $107K | Sell |
12,663
-63
| -0.5% | -$457 | ﹤0.01% | 2726 |
|
|
2023
Q3 | $98.6K | Buy |
12,726
+326
| +3% | +$2.98K | ﹤0.01% | 2731 |
|
|
2023
Q2 | $142K | Buy |
+12,400
| New | +$128K | ﹤0.01% | 2645 |
|
|
2021
Q3 | – | Sell |
-229
| Closed | -$1K | – | 3531 |
|
|
2021
Q2 | $1K | Sell |
229
-12,671
| -98% | -$57.4K | ﹤0.01% | 3479 |
|
|
2021
Q1 | $61K | Hold |
12,900
| – | – | ﹤0.01% | 3177 |
|
|
2020
Q4 | $92K | Sell |
12,900
-11,400
| -47% | -$110K | ﹤0.01% | 3054 |
|
|
2020
Q3 | $259K | Hold |
24,300
| – | – | ﹤0.01% | 2537 |
|
|
2020
Q2 | $307K | Buy |
24,300
+8,600
| +55% | +$100K | ﹤0.01% | 2458 |
|
|
2020
Q1 | $144K | Sell |
15,700
-9,100
| -37% | -$104K | ﹤0.01% | 2619 |
|
|
2019
Q4 | $346K | Sell |
24,800
-700
| -3% | -$10.2K | ﹤0.01% | 2467 |
|
|
2019
Q3 | $439K | Hold |
25,500
| – | – | ﹤0.01% | 2390 |
|
|
2019
Q2 | $694K | Buy |
25,500
+11,100
| +77% | +$254K | ﹤0.01% | 2207 |
|
|
2019
Q1 | $276K | Sell |
14,400
-9,400
| -39% | -$122K | ﹤0.01% | 2573 |
|
|
2018
Q4 | $224K | Hold |
23,800
| – | – | ﹤0.01% | 2664 |
|
|
2018
Q3 | $450K | Hold |
23,800
| – | – | ﹤0.01% | 2463 |
|
|
2018
Q2 | $465K | Buy |
23,800
+6,000
| +34% | +$119K | ﹤0.01% | 2480 |
|
|
2018
Q1 | $334K | Buy |
17,800
+2,100
| +13% | +$45.4K | ﹤0.01% | 2524 |
|
|
2017
Q4 | $261K | Buy |
15,700
+2,000
| +15% | +$34.3K | ﹤0.01% | 2637 |
|
|
2017
Q3 | $282K | Buy |
13,700
+1,600
| +13% | +$18.1K | ﹤0.01% | 2620 |
|
|
2017
Q2 | $108K | Sell |
12,100
-1
| -0% | -$10 | ﹤0.01% | 3077 |
|
|
2017
Q1 | $160K | Buy |
12,101
+1
| +0% | +$12 | ﹤0.01% | 2845 |
|
|
2016
Q4 | $154K | Hold |
12,100
| – | – | ﹤0.01% | 2858 |
|
|
2016
Q3 | $145K | Buy |
12,100
+9,200
| +317% | +$125K | ﹤0.01% | 2880 |
|
|
2016
Q2 | $32K | Hold |
2,900
| – | – | ﹤0.01% | 3110 |
|
|
2016
Q1 | $25K | Buy |
+2,900
| New | +$32.9K | ﹤0.01% | 3108 |
|
Other funds holding VYGR
AC
VPC
OM
New York State Common Retirement Fund's VYGR Position: Q2 2026 in Review
New York State Common Retirement Fund held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 12,732 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.
New York State Common Retirement Fund first reported a position in VYGR in Q1 2016 and has held it in 35 quarters since. The position peaked at $694K in Q2 2019. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- New York State Common Retirement Fund held 12,732 shares of Voyager Therapeutics worth $44.6K as of Q2 2026.
- New York State Common Retirement Fund left its Voyager Therapeutics share count unchanged in Q2 2026.
- Voyager Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3031 holding.
- New York State Common Retirement Fund first reported a position in Voyager Therapeutics in Q1 2016 and has held it in 35 quarters since.
- New York State Common Retirement Fund's Voyager Therapeutics position peaked at $694K in Q2 2019.
- 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.